Contact us: +49 (0)173 8859971
During Clinical Evaluation, we collect, appraise, and analyze all relevant data around the clinical use of your medical device. This proves the safety and performance of your product and demonstrates that it meets the intended purpose and clinical benefit.
The evaluation process for in vitro diagnostics includes clinical performance, analytical performance, and scientific validity. This ensures that your IVD achieves the intended clinical benefit and complies with the requirements of the IVDR.
We develop appropriate Post-Market Surveillance strategies and conduct suitable activities to monitor the use of your medical device in the market. This way, we can verify the performance of your product and ensure increased safety of your medical device by identifying unknown risks.
As a manufacturer of medical devices, you must develop, implement, and maintain a QM system in accordance with MDR and IVDR. Depending on its risk class, a certified QM system according to ISO 13485 and the requirements of MDR/IVDR is mandatory.
As a manufacturer of medical devices, it is required to ensure the biological safety of the product in accordance with the ISO 10993. Biological risks, such as the toxicity of used materials or production residues, must be minimized.
A carefully implemented Risk Management process can significantly improve the safety of a medical device right from the development phase. Risks arising from a product are systematically recorded and minimized through suitable measures.
The State of the Art evaluation is essential for established products as well as for products under development. It identifies risks and benefits of similar devices and medical alternatives. The State of the Art evaluation provides input for the Risk Management for PMS and is the basis for the Clinical Evaluation. A strong State of the Art evaluation is the foundation of a successful CE certification.
Providing a Summary of Safety and Clinical Performance (SSCP) or a Summary of Safety and Performance (SSP) has been mandatory for manufacturers of higher risk medical devices or in vitro diagnostics, respectively, since the Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR) were introduced in 2017. We will support you in meeting the increased level of requirements.
PRO-LIANCE has prepared a complete clinical and a complete biological evaluation for a product group. These were completed exactly within the promised time. In the course of the completion, the two experts were very professional, helpful and accommodating. The produced documents make an excellent impression.
Martin von Rüden,
Regulatory Affairs Manager at QUESTALPHA GmbH
I find the level of advice and feedback on the clinical evaluation process to be very valuable, this is where real collaboration takes place.
Sr. Director Clinical Affairs,
World market leader in the field of industrial endoscopy
With the quality management advice from PRO-LIANCE
we are completely satisfied!!
QM manager, manufacturer of medical products for dermatology,
plastic surgery and aesthetic medicine
In the course of Regulatory Affairs Consulting
we always had a permanent contact person.
Managing director, manufacturer of medical textiles
for chronic inflammatory skin diseases
PRO-LIANCE staff is very professional, they deliver high quality documents within agreed timelines, they are very responsive and flexible to changes sometimes on a very short notice. A great pleasure to work with!
Sr. Scientific Expert, Pharmaceutical Manufacturer for category-leading injectables, devices, and skincare products
Good communication and support, especially with the new challenges of MDR and MDCG documents.
Team Lead Clinical Product Management,
Manufacturer of Sustainable Solutions for Ophthalmology
The flexibility, speed, and communication of the PRO-LIANCE staff were great! I found the constructive discussions particularly valuable.
Medical Affairs Manager,
manufacturer of medical devices with a focus on inhalation devices
The workshop was geared exactly towards our target group and every question was answered. The content was very well presented and the scope of topics covered aswell as the time frame were perfect. We would be happy to do it again.
Workshop participant
Communication and processing time was fast and uncomplicated.
Workshop participant
Friendly communication and quick response to questions.
Workshop participant
Communication was excellent. We tried to find pragmatic approaches together, which worked out well. The deadlines we were given were always met, even if they were often strict. I have already worked with PRO-LIANCE at my previous employer and I am very happy that I was able to convince my current employer to do the same.
Workshop participant
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information